Zhao Guoqiang, Li Yanru, Wang Xiaoyi, Ding Xiu, Wang Chunyan, Xu Wen, Han Demin
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Obstructive Sleep Apnea-Hypopnea Syndrome Clinical Diagnosis and Therapy and Research Centre, Capital Medical University, Beijing, China.
Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1579-1586. doi: 10.1007/s00405-018-4984-6. Epub 2018 Apr 25.
Both surgical treatment and non-surgical treatment are suggested by clinicians for children with habitual snoring related to adenotonsillar hypertrophy; However, how should the decision be made remains unclear. The objective of this study was to investigate potential predictors for the treatment decision, i.e., surgical treatment vs wait and see in children with habitual snoring related to adenoidal and/or tonsillar hypertrophy.
Children with complaints of snoring and/or apnea associated with adenotonsillar hypertrophy who received polysomnography (PSG) monitoring at our Hospital were recruited. After at least 6 months, the subjects were followed up and grouped according to whether or not they had received adenoidectomy and/or tonsillectomy (AT) execution. The heights, weights, as well as the quality of life (assessed using the obstructive sleep apnea-18 (OSA-18) quality of life questionnaire) and baseline PSG of the subjects were recorded and compared. Two logistic regressions were performed to reveal the factors influencing decision-making on conducting AT.
A total of 509 children were finally included (345 males and 164 females). Among these children, 287 eventually received AT. Significant differences in age, scores for item 1 and 5 of the OSA-18, apnea-hypopnea index, obstructive apnea index, obstructive apnea-hypopnea index (OAHI), and Lowest arterial oxygen saturation (P < 0.05) were observed between groups. By multivariate logistic regression, the factors that influenced the surgical decision were identified as follows: age < 7 years (P = 0.008: odds ratio [OR] = 1.667, 95% confidence interval [CI] 1.140-2.438), score for item 5 of OSA-18 > 4 points (P = 0.042: OR = 1.489, 95% CI 1.014-2.212) and OAHI > 1/h (P = 0.044: OR = 1.579, 95% CI 1.013-2.463).
School-age children aged < 7 years, with OAHI > 1/h and mouth breathing scored > 4 points were more likely to receive AT during the disease process and thus require increased attention.
临床医生对与腺样体扁桃体肥大相关的习惯性打鼾儿童既建议手术治疗,也建议非手术治疗;然而,应如何做出决策仍不明确。本研究的目的是调查治疗决策的潜在预测因素,即对与腺样体和/或扁桃体肥大相关的习惯性打鼾儿童进行手术治疗与观察等待。
招募在我院接受多导睡眠图(PSG)监测的有打鼾和/或呼吸暂停主诉且与腺样体扁桃体肥大相关的儿童。至少6个月后,对受试者进行随访,并根据他们是否接受了腺样体切除术和/或扁桃体切除术(AT)进行分组。记录并比较受试者的身高、体重以及生活质量(使用阻塞性睡眠呼吸暂停18(OSA-18)生活质量问卷进行评估)和基线PSG。进行了两个逻辑回归分析以揭示影响实施AT决策的因素。
最终纳入509名儿童(345名男性和164名女性)。在这些儿童中,287名最终接受了AT。两组之间在年龄、OSA-18第1项和第5项得分、呼吸暂停低通气指数、阻塞性呼吸暂停指数、阻塞性呼吸暂停低通气指数(OAHI)以及最低动脉血氧饱和度方面观察到显著差异(P<0.05)。通过多变量逻辑回归分析,确定影响手术决策的因素如下:年龄<7岁(P = 0.008:比值比[OR]=1.667,95%置信区间[CI]1.140 - 2.438)、OSA-18第5项得分>4分(P = 0.042:OR = 1.489,95%CI 1.014 - 2.212)和OAHI>1次/小时(P = 0.044:OR = 1.579,95%CI 1.013 - 2.463)。
年龄<7岁、OAHI>1次/小时且口呼吸得分>四分的学龄儿童在疾病过程中更有可能接受AT,因此需要更多关注。